-
681
-
682
-
683
Faecalibacterium prausnitzii: A Next-Generation Probiotic in Gut Disease Improvement
Published 2021-01-01Get full text
Article -
684
Bioinspired artificial antioxidases for efficient redox homeostasis and maxillofacial bone regeneration
Published 2025-01-01Get full text
Article -
685
-
686
The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome
Published 2024-12-01Get full text
Article -
687
A ketogenic diet regulates microglial activation to treat drug addiction
Published 2025-01-01Get full text
Article -
688
A Novel COL7A1 Mutation in a Patient With Dystrophic Epidermolysis Bullosa. Successful Treatment With Upadacitinib
Published 2025-01-01“…Shuqin Lai,* Chunli Lin,* Zimeng Guo, Yun Lai, Ling Xie, Chunlei Wan, Tao Yang, Longnian Li Department of Dermatology, Candidate Branch of National Clinical Research Centre for Skin and Immune Diseases, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Tao Yang; Longnian Li, Department of Dermatology, Candidate Branch of National Clinical Research Centre for Skin and Immune Diseases, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, People’s Republic of China, Email danny20021068@126.com; li_longnian@foxmail.comAbstract: Dystrophic epidermolysis bullosa (DEB) is a heterogeneous and rare genetic skin disease caused by mutations in the COL7A1 gene, which encodes Type VII collagen. …”
Get full text
Article -
689
-
690
-
691
-
692
Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake
Published 2012-01-01Get full text
Article -
693
-
694
Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian Cancer
Published 2016-01-01Get full text
Article -
695
-
696
-
697
-
698
Assessment of vitamin D status in obese and non-obese patients: A case-control study
Published 2025-01-01Get full text
Article -
699
-
700